These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9068748)

  • 1. Cutis marmorata telangiectatica congenita associated with an elevated maternal serum human chorionic gonadotrophin level and transitory isolated fetal ascites.
    Chen CP; Chen HC; Liu FF; Jan SW; Chern SR; Wang TY; Hung HY
    Br J Dermatol; 1997 Feb; 136(2):267-71. PubMed ID: 9068748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bilateral congenital glaucoma in a child with cutis marmorata telangiectatica congenita: a case report].
    Spitzer MS; Szurman P; Rohrbach JM; Aisenbrey S
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):66-9. PubMed ID: 17260324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results.
    Chen CP; Chern SR; Liu FF; Jan SW; Lee CC; Chang YC; Yue CT
    Prenat Diagn; 1997 Jun; 17(6):571-6. PubMed ID: 9203216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
    Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
    Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutis marmorata telangiectatica congenita with multiple congenital anomalies.
    Del Giudice SM; Nydorf ED
    Arch Dermatol; 1986 Sep; 122(9):1060-1. PubMed ID: 3740886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutis marmorata telangiectatica congenita: a prospective study of 27 cases and review of the literature with proposal of diagnostic criteria.
    Kienast AK; Hoeger PH
    Clin Exp Dermatol; 2009 Apr; 34(3):319-23. PubMed ID: 19196300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adams-Oliver syndrome with widespread CMTC and fatal pulmonary vascular disease.
    Dadzie OE; Tyszczuk L; Holder SE; Teixeira F; Charakida A; Scarisbrick J; Chu A
    Pediatr Dermatol; 2007; 24(6):651-3. PubMed ID: 18035989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI findings in macrocephaly-cutis marmorata telangiectatica congenita.
    Carcao M; Blaser SI; Grant RM; Weksberg R; Siegel-Bartelt J
    Am J Med Genet; 1998 Mar; 76(2):165-7. PubMed ID: 9511980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrocephaly-cutis marmorata telangiectatica congenita: A case report and review of salient features.
    Katugampola R; Moss C; Mills C
    J Am Acad Dermatol; 2008 Apr; 58(4):697-702. PubMed ID: 18342719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations.
    Wright DR; Frieden IJ; Orlow SJ; Shin HT; Chamlin S; Schaffer JV; Paller AS
    Arch Dermatol; 2009 Mar; 145(3):287-93. PubMed ID: 19289759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutis Marmorata Telangiectatica Congenita Presenting as a Fetal Hemothorax.
    Mon RA; Mozurkewich E; Treadwell MC; Berman DR
    Fetal Diagn Ther; 2019; 45(4):281-284. PubMed ID: 29791897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between perinatal outcome of singleton pregnancies and isolated highly elevated levels of maternal serum human chorionic gonadotropin at mid-gestation.
    Tavor O; Shohat M; Lipitz S
    Isr Med Assoc J; 2007 Jul; 9(7):509-12. PubMed ID: 17710780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
    Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very low alpha-fetoprotein in Down syndrome maternal serum screening.
    Muller F; Dreux S; Sault C; Galland A; Puissant H; Couplet G; Lemay C; Larcher ME; Renom G;
    Prenat Diagn; 2003 Jul; 23(7):584-7. PubMed ID: 12868089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.